Free Trial
NYSE:MED

Medifast (MED) Stock Price, News & Analysis

Medifast logo
$14.47 -0.21 (-1.43%)
Closing price 07/11/2025 03:58 PM Eastern
Extended Trading
$14.42 -0.05 (-0.35%)
As of 07/11/2025 07:34 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Medifast Stock (NYSE:MED)

Key Stats

Today's Range
$14.39
$14.68
50-Day Range
$12.48
$15.21
52-Week Range
$11.57
$22.66
Volume
150,073 shs
Average Volume
236,419 shs
Market Capitalization
$159.03 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$16.50
Consensus Rating
Hold

Company Overview

Medifast Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
70th Percentile Overall Score

MED MarketRank™: 

Medifast scored higher than 70% of companies evaluated by MarketBeat, and ranked 63rd out of 153 stocks in the consumer staples sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Medifast has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no buy ratings, 1 hold rating, and no sell ratings.

  • Amount of Analyst Coverage

    Medifast has received no research coverage in the past 90 days.

  • Read more about Medifast's stock forecast and price target.
  • Earnings Growth

    Earnings for Medifast are expected to grow by 200.00% in the coming year, from $0.51 to $1.53 per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Medifast is -22.26, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Medifast is -22.26, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Medifast has a P/B Ratio of 0.75. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

  • Read more about Medifast's valuation and earnings.
  • Percentage of Shares Shorted

    17.96% of the float of Medifast has been sold short.
  • Short Interest Ratio / Days to Cover

    Medifast has a short interest ratio ("days to cover") of 7.8.
  • Change versus previous month

    Short interest in Medifast has recently increased by 13.94%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Medifast does not currently pay a dividend.

  • Dividend Growth

    Medifast does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    17.96% of the float of Medifast has been sold short.
  • Short Interest Ratio / Days to Cover

    Medifast has a short interest ratio ("days to cover") of 7.8.
  • Change versus previous month

    Short interest in Medifast has recently increased by 13.94%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Medifast has a news sentiment score of 0.76. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.89 average news sentiment score of Consumer Staples companies.
  • News Coverage This Week

    MarketBeat has tracked 2 news articles for Medifast this week, compared to 3 articles on an average week.
  • Search Interest

    Only 1 people have searched for MED on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Medifast insiders have bought more of their company's stock than they have sold. Specifically, they have bought $5,003.00 in company stock and sold $0.00 in company stock.

  • Percentage Held by Insiders

    Only 2.90% of the stock of Medifast is held by insiders.

  • Percentage Held by Institutions

    95.51% of the stock of Medifast is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Medifast's insider trading history.
Receive MED Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Medifast and its competitors with MarketBeat's FREE daily newsletter.

MED Stock News Headlines

Presidential Bombshell: $150T Resource to Be Released as soon as this Summer?
Something extraordinary is happening in Washington. For the first time in over a century, a sitting President could release a national treasure that's been tied up in red tape, for generations. I'm talking about a $150 trillion American asset that's scattered across all 50 states. While the mainstream media focuses on political theater, this story is quietly developing behind closed doors.
Medifast Stock Guidance | NYSE:MED - Benzinga
Medifast: Coach Surge Fuels Growth
See More Headlines

MED Stock Analysis - Frequently Asked Questions

Medifast's stock was trading at $17.62 at the beginning of the year. Since then, MED shares have decreased by 17.9% and is now trading at $14.47.

Medifast Inc (NYSE:MED) issued its quarterly earnings data on Monday, April, 28th. The specialty retailer reported ($0.11) EPS for the quarter, missing the consensus estimate of ($0.07) by $0.04. The specialty retailer earned $115.73 million during the quarter, compared to analysts' expectations of $114.85 million. Medifast had a positive trailing twelve-month return on equity of 6.63% and a negative net margin of 1.29%.
Read the conference call transcript
.

Medifast's top institutional investors include Chickasaw Capital Management LLC (0.13%). Insiders that own company stock include Daniel R Chard, Scott Schlackman, Andrea B Thomas, Jeffrey J Brown and Constance J Hallquist.
View institutional ownership trends
.

Shares of MED stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Medifast investors own include American Water Works (AWK), Waste Connections (WCN), Humana (HUM), The RMR Group (RMR), DiamondRock Hospitality (DRH), Voyager Therapeutics (VYGR) and AU Optronics (AUOTY).

Company Calendar

Last Earnings
4/28/2025
Today
7/13/2025
Next Earnings (Estimated)
8/04/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NYSE
Industry
FOOD - MISC/DIVERSIFIED
Sub-Industry
Personal Products
Current Symbol
NYSE:MED
CIK
910329
Employees
870
Year Founded
N/A

Price Target and Rating

High Price Target
$16.50
Low Price Target
$16.50
Potential Upside/Downside
+14.0%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
1 Analysts

Profitability

EPS (Trailing Twelve Months)
($0.65)
Trailing P/E Ratio
N/A
Forward P/E Ratio
28.37
P/E Growth
N/A
Net Income
$2.09 million
Net Margins
-1.29%
Pretax Margin
-1.34%
Return on Equity
6.63%
Return on Assets
4.81%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
3.52
Quick Ratio
2.87

Sales & Book Value

Annual Sales
$602.46 million
Price / Sales
0.26
Cash Flow
$2.95 per share
Price / Cash Flow
4.90
Book Value
$19.21 per share
Price / Book
0.75

Miscellaneous

Outstanding Shares
10,990,000
Free Float
10,672,000
Market Cap
$159.03 million
Optionable
Optionable
Beta
0.86

Social Links

10 Stocks Set to Soar in Summer 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (NYSE:MED) was last updated on 7/13/2025 by MarketBeat.com Staff
From Our Partners